Just in time for the holidays, we’re releasing our brand new drug launch application to bring you – more insights – better market view – faster! Thanks to the rise of global value growth for specialist and biologic products, traditional success predictors such as company size and reputation, funds or a valuable product- do not suffice in today’s competitive market of smaller, highly targeted drug launches. That’s why Verix has developed the new drug launch application, dedicated to optimize 3 crucial factors for a successful drug launch: TtM, precise positioning and performance during the first 6 months.
In the past years, Pharma companies have demonstrated exceptional leadership in innovation with new therapies that expand the benefits to patients and delivery systems to improve convenience and adherence, but here is the catch: Drugs don’t work on patients who don’t take them!
What does it take to successfully launch a new drug in today’s competitive Pharma market? That is the question. Although cracking the code for an ever-successful launch is impossible due to constant external world-wide developments, two qualities stand out as being the most essential for every launch plan to overcome today’s competitive landscape. Find out how these two components have become the bread and butter of drug launch today, giving pharmaceutical companies the edge they need to overcome today’s ruthless competition.
You’ve got data in your hands, but data discrepancies are rendering your sales teams less efficient. How can Pharma put data analytics to good use and get a holistic view of commercial operations effectiveness? Put the data your organization already has at its disposal into the hands of the sales force teams – in meaningful ways. With a real-time, holistic view of data, your data analytics solution will finally deliver on expectations.
In this published series of articles, discover how your organization can adopt tactics toward better relationships with your patients/customers and between sales and marketing, as well as view the significance that technology collaborations offer.
How can your commercial operations team maneuver through the landmines? Patent expirations, downsizing, mergers – these are just a few of the dynamics forcing pharma to change. Commercial operations teams can confidently win the game with agile data integration and field force applications – but only if their data is accurate, up-to-date and timely.
Today’s pharma landscape calls for a new way of thinking about innovation. Instead of a technology buy-out, partnerships are the way to go. Collaboration bridges the divide between pharma’s conservative processes and technology’s nimble pioneering wins.
“The empowered patient is dead! Long live the expectant patient!” says Emma D’Arcy. Health hedonists, health deniers, cybercondriacs… It’s all about patient centricity these days and no doubt everyone in Pharma wants to provide a positive customer experience. But is it that simple?
It’s well known that one of the next challenges in Pharma is without a doubt fixing those data ‘black holes’ created by missing data and data inaccuracies. Ever since Big Data came into play, and thanks to data providers such as IMS etc., data flow today is unstoppable. But problems like multiple data sources and missing crucial information like patient ID’s, are literally keeping Pharma analysts up at night. Download this article to learn more on data discrepancies and its implications on Pharma companies.
Need business answers for the here and now? Are you willing to depend on your analytics team for every little report? Or are you ready for on-the-spot accurate data insights that allow you to make real-time business decisions? Leave the analytics teams to worry about the deeper analyses and answer the more complex questions.
According to the Institute of Medicine, unnecessary medical costs total almost $750 billion, while as much as $317.4 billion due to medication non-adherence could be prevented by robust patient health education efforts. In other words, if we want to improve our drug performances, lower the costs for healthcare providers, and most importantly- ensure better drug results for patients- we need an additional agent to oversee the prescribed medication treatments, and make sure patients follow through; another link to connect between the pharmaceutical medication instructions, the physician’s medical prescriptions and the actual day-to-day treatment. This missing link is bound to be the nurse.
How complex is the shift from one 3rd party data source provider to the other and how dependent are you today on your existing solution? Mainly how painful – if at all – would it be to switch? Download this free article to debunk a few myths and check how Daiichi Sankyo transferred from IMS to Symphony Health painlessly and successfully.
Can you honestly say you are positive that building a Pharma data analytics solution in-house will deliver faster and better results than buying one? In Pharma, an outsourced, Big Data end-to-end analytics solution can really build the business case and lead to optimized sales and effective marketing spend. Don’t take our word for it, see for yourself! Download our “Moving from BI to Big Data Analytics in Pharma Build it or Buy it” free article now.
With the ever growing managed care data available, management teams are left too often with over a dozen different spreadsheets to single out the right information to boost sales. In days of challenges like these, what happens when you win an account or get a formulatory status improvement? Mainly, how does your sales organization call on the right doctors and quickly capitalize on wins? In this free whitepaper learn how to quickly pinpoint top payers with preferred access, develop campaigns to reach them, analyze pull-through data and subsequently identify the best targets for the reps to call upon – all at the push of a button.
As someone who knows the power of data and analytics, Charlotte Sibley is not afraid to “tell truth to power” or say “your baby is ugly.” In our exclusive interview, the President of Sibley Associates and a well-known industry iconoclast points out to ultra-modern data analytics as the key to delivering good, solid customer service and truly boosting pharma commercial operations. Read on to discover how ultra-modern analytics can boost pharma commercial operations, hospitals and healthcare systems are way ahead of Pharma, and being patient centric is about “shutting up and listening”. Download the in depth interview with Charlotte Sibley on the importance of analytics.
This week we have had the opportunity to interview Cindie Dilley, President of PMSA. Dilley is an authority on trends in Pharma analytics and a recognized figure in her field. We discussed her views on Pharma most critical topics: What are the challenges faced by the industry? Who are the influencers paving the way? What are some of the game-changing strategies in data analytics? Why should data scientists feel like “Kings of the World with great responsibilities”? Download this in depth interview to discover the latest trends and what it takes to become a leader in Pharma analytics.
Today’s healthcare landscape is changing, though reps remain the primary means to deliver information. It is becoming more difficult for sales reps to overcome access restrictions placed on them. As access to physicians decline, what are the changes needed to enable commercial teams to successfully sell their products? What are the strategies and tools sales reps need to overcome these barriers and boost sales. Download your free copy today.
Over the next five years, specialty drugs are expected to be the biggest drivers of branded drug spend growth, with investment projecting to increase 30%. Why is that? How can you leverage this trend? In this free white paper, we review industry trends, hurdles to entry, impact to commercialization strategies and analysis tips. Are you ready to make the move to specialty medicines? Download your free copy today.
In the pharma industry, analysts are constantly being approached by everyone in the company at the same time. The requests all appear to be urgent and must be addressed in a timely manner. In light of the amount of data being collected, how can you best utilize your analysts? In this whitepaper, we will indicate the seven tips that can be implemented to empower your pharma analysts to be proactive rather than reactive.
The Affordable Care Act was put into place to address the skyrocketing costs of health care in the US. But what does it mean for the pharmaceutical industry? In this whitepaper we aim to address the three major components of ACA that impact pharma and highlight strategies that can help your business take advantage of ACA. Download the whitepaper now to learn more.
Have you ever clogged up your kitchen sink and not known why? Did you grab the plunger or did you call an expensive plumber to resolve the emergency? Managing a sales pipeline, especially in the complex life sciences industry, can often leave you feeling like you’ve lost control and calling a plumber is the only answer. Download this free whitepaper to learn how you can properly manage your sales pipeline.
Tired of entering sales calls blindly? Pharmaceutical sales is a job that demands endless creativity and planning. Reps have an average of 2-3 minutes to convince doctors that their drug is the best on the market. In this free whitepaper, we’ve outlined the top 5 practices that can help reps plan sales calls more efficiently and effectively. Download it today and start preventing sales call blindness.
Is your managed markets team getting the support it needs? The business of marketing and selling drugs has changed. While Sales Reps remain the vital link to the physician, the Account Managers are integral to the ultimate success of your drug. Unfortunately, the Managed Markets team is often the last group to receive analytical support. Download this whitepaper and learn how you could be better supporting your managed markets team.
Do you struggle filtering through the noise of big data? Traditional BI solutions are accompanied by a host of problems such as the silo effect, sending out junk alerts, or simply not be aligned with the complexity of the data. Big Data can be great but ONLY if you can filter through the noise to get the info that really matters.In this free whitepaper, learn how Verix’s Intelligent Business Alerts (HotSpots) platform can provide your company with insightful analysis to significantly improve business performance.
With the amount of organizational data growing at an exponential rate, the issue of analysis and response times is becoming more and more crucial. Is your BI solution still relying on technology that loads data onto the disk in the form of tables and multi-dimensional cubes against which queries are run? This could be slowing you down. Download this free whitepaper to learn how in-memory capabilities can deliver faster and more reliable data analysis.